ARTIFICIAL INTELLIGENCE
Harnessing AI to Accelerate Smarter Drug Development
Turning Altasciences' Vision for Artificial Intelligence and Into Actionable Intelligence
Artificial intelligence is more than a technological advancement—it's a strategic enabler. As a partner in early-phase drug development, we’re committed to using AI responsibly and intentionally to elevate our people, empower our clients, and transform the speed and precision of decision-making in drug research.
Our AI vision is built on three foundational principles
1. AI Literacy for Every Employee
We believe that the power of AI begins with people. That’s why we are investing in AI literacy across our teams, ensuring every employee—from laboratory scientists to project managers—is equipped to understand and leverage AI tools confidently and ethically.
With this foundation, our staff can deliver faster, and more personalized service to our clients, using AI by design—not just by chance.
2. Refocusing on Science and Strategy
AI doesn’t replace our people, it frees them to do what they do best. By automating repetitive, time-consuming tasks, our teams can focus more deeply on scientific insight, strategic planning, and human expertise. This means more thoughtful study designs, faster turnarounds, and increased capacity to support innovative therapies across all phases of early development.
3. Turning 30 Years of Experience Into Actionable Intelligence
With over three decades of experience in nonclinical, clinical, bioanalytical, and manufacturing services, Altasciences has conducted thousands of studies—many of which have led to successful treatments, and some that revealed critical early stage failures.
Now, we’re aggregating this data and building AI tools that structure and analyze this institutional knowledge, transforming it into a dynamic resource that our clients can use to guide early development decisions.
From protocol optimization to risk identification, our AI-enabled platforms will allow sponsors to tap into our historical insights, learning from what has worked and what hasn’t, to shape stronger, more informed programs from day one.
The Future is Human AND AI
At Altasciences, we see AI as a force multiplier, not a replacement. Our vision is one where human expertise and artificial intelligence work together, delivering faster answers, smarter decisions, and better outcomes for patients everywhere.
We empower our people, focus our time on the right work, and apply decades of experience through intelligent systems.
We don’t just use AI, we make it meaningful.
Learn more about the evolving role of artificial intelligence in early-phase drug development.
Connect with our experts